A detailed history of World Equity Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, World Equity Group, Inc. holds 7,700 shares of ABBV stock, worth $1.29 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
7,700
Previous 8,096 4.89%
Holding current value
$1.29 Million
Previous $1.39 Billion 9.52%
% of portfolio
0.55%
Previous 0.41%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $64,880 - $78,934
-396 Reduced 4.89%
7,700 $1.52 Billion
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $63,309 - $73,930
409 Added 5.32%
8,096 $1.39 Billion
Q1 2024

Jul 18, 2024

BUY
$159.82 - $182.1 $1.23 Million - $1.4 Million
7,687 New
7,687 $1.4 Billion
Q4 2023

Jul 22, 2024

BUY
$137.6 - $154.97 $39,353 - $44,321
286 Added 3.38%
8,750 $1.36 Billion
Q3 2023

Jul 22, 2024

BUY
$133.59 - $154.65 $49,161 - $56,911
368 Added 4.55%
8,464 $1.27 Billion
Q2 2023

Aug 26, 2024

SELL
$132.51 - $164.9 $1.24 Million - $1.54 Million
-9,349 Reduced 51.56%
8,785 $1.18 Billion
Q1 2023

Aug 26, 2024

BUY
$144.61 - $166.54 $1.45 Million - $1.67 Million
10,038 Added 123.99%
18,134 $1.13 Billion
Q4 2022

Sep 06, 2024

BUY
$138.31 - $165.87 $44,120 - $52,912
319 Added 2.51%
13,015 $2.1 Billion
Q3 2022

Sep 06, 2024

BUY
$134.21 - $153.93 $617,366 - $708,078
4,600 Added 56.82%
12,696 $1.7 Billion
Q2 2022

Sep 06, 2024

SELL
$137.62 - $174.96 $37,707 - $47,939
-274 Reduced 1.85%
14,525 $2.22 Billion
Q1 2022

Sep 06, 2024

BUY
$131.98 - $163.75 $884,661 - $1.1 Million
6,703 Added 82.79%
14,799 $2.4 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track World Equity Group, Inc. Portfolio

Follow World Equity Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on World Equity Group, Inc. with notifications on news.